List view / Grid view
18 November 2015 | By Victoria White
When studying prototype antibodies that target a specific weak spot on HIV, the researchers noted two of the antibodies had an unusual feature that could prove important in vaccine design...
10 November 2015 | By Victoria White
Sanofi Pasteur's experimental vaccine is a novel synthetic vaccine generated from key genetic sequences of many flu viruses...
3 November 2015 | By Kate Douetil
The European AIDS Vaccine Initiative (EAVI2020) is a new EUR 23 million project, financed by the European Commission...
28 September 2015 | By Victoria White
H7N9 candidate vaccines have failed to elicit a strong immune response necessary to protect from infection. A study has revealed that it may be due to immune camouflage...
25 September 2015 | By Victoria White
When eCD4-lg was tested in animal models, the results were so powerful and effective that they suggested the compound’s potential to serve the role of an alternative HIV/AIDS vaccine...
17 September 2015 | By Vicky White
By identifying ERManI as the target that slows the spread of HIV-1, researchers have revealed a target in which future therapies can be developed...
15 September 2015 | By Victoria White
Researchers have discovered a new gene, USP19, involved in the muscle wasting syndrome cachexia that could be a good target for drug development...
7 September 2015 | By Victoria White
The ranking recognises Kymab’s potential for rapid future sales growth and increasing international presence...
18 August 2015 | By Victoria White
Researchers have discovered a small molecule, known as CLR01, that attacks the HIV virus and disrupts the amyloids in semen that promote HIV infection...
17 August 2015 | By Victoria White
Scientists have created a liver-on-chip device mimicking human physiology, leading to the discovery of a new mechanism of paracetamol toxicity...
31 July 2015 | By Victoria White
Researchers identify a pair of master regulators that control the fate of follicular helper T (TFH) cells - a finding that could improve vaccine design...
29 July 2015 | By Victoria White
Scientists have precisely modifed human T cells using the CRISPR genome-editing system- a breakthrough that could lead to CRISPR/Cas9-based therapies...
20 July 2015 | By Victoria White
Lower levels of cholesterol in certain immune cells may help explain why some HIV-infected people are able to naturally control disease progression...
14 July 2015 | By Victoria White
The Francis Crick Institute and GSK are to partner up to explore new avenues of medical research and drug discovery across a broad range of diseases...
9 July 2015 | By Victoria White
Scientists have shown that didehydro-Cortistatin A reduces residual levels of HIV virus from dormant cells, establishing a near-permanent state of latency...
